We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.9B
AUM Growth
-$7.79M
Cap. Flow
+$168M
Cap. Flow %
4.3%
Top 10 Hldgs %
35.61%
Holding
2,467
New
803
Increased
446
Reduced
430
Closed
506

Sector Composition

Rank Sector Weight
1 Financials 11.26%
2 Technology 6.44%
3 Industrials 6.05%
4 Consumer Discretionary 5.05%
5 Healthcare 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSPR
776
DELISTED
Casper Sleep Inc.
CSPR
$738K 0.02%
+110,472
New +$591K
JD icon
777
JD.com
JD
$45.1B
$737K 0.02%
10,519
-52,419
-83% -$4.15M
CYBR
778
DELISTED
CyberArk
CYBR
$736K 0.02%
4,250
-600
-12% -$105K
VRTX icon
779
Vertex Pharmaceuticals
VRTX
$133B
$736K 0.02%
3,350
+1,096
+49% +$213K
ASML icon
780
ASML
ASML
$672B
$732K 0.02%
+919
New +$730K
TASK icon
781
TaskUs
TASK
$655M
$731K 0.02%
+13,551
New +$739K
CL icon
782
Colgate-Palmolive
CL
$74.2B
$730K 0.02%
8,553
+3,690
+76% +$288K
RF icon
783
Regions Financial
RF
$26.7B
$729K 0.02%
+33,420
New +$764K
MCAAU
784
DELISTED
Mountain & Co. I Acquisition Corp. Unit
MCAAU
$729K 0.02%
+71,357
New +$727K
TCOM icon
785
Trip.com Group
TCOM
$29.5B
$727K 0.02%
29,536
-5,735
-16% -$162K
CSW
786
CSW Industrials
CSW
$5.65B
$724K 0.02%
5,991
+3,440
+135% +$448K
REGN icon
787
Regeneron Pharmaceuticals
REGN
$82.6B
$723K 0.02%
1,145
+323
+39% +$199K
KMX icon
788
CarMax
KMX
$8.4B
$722K 0.02%
5,541
-6,096
-52% -$854K
TSN icon
789
Tyson Foods
TSN
$20.3B
$721K 0.02%
8,277
-517
-6% -$42.5K
FLOW
790
DELISTED
SPX FLOW, Inc.
FLOW
$720K 0.02%
8,331
+4,840
+139% +$389K
LMT icon
791
Lockheed Martin
LMT
$140B
$719K 0.02%
+2,023
New +$700K
STKL
792
CALL
DELISTED
SunOpta
STKL
$719K 0.02%
+103,500
New +$749K
TBCPU
793
DELISTED
Thunder Bridge Capital Partners III Inc. Units
TBCPU
$719K 0.02%
72,309
-83,634
-54% -$832K
AVHIU
794
DELISTED
Achari Ventures Holdings Corp I Unit
AVHIU
$715K 0.02%
+70,506
New +$718K
IPOD
795
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
$713K 0.02%
69,736
+20,500
+42% +$210K
PCRX icon
796
Pacira BioSciences
PCRX
$973M
$712K 0.02%
+11,827
New +$652K
WBD icon
797
PUT
Warner Bros
WBD
$67.6B
$706K 0.02%
30,000
UTAAU
798
DELISTED
UTA Acquisition Corporation Units
UTAAU
$706K 0.02%
+70,000
New +$702K
NFNT.U
799
DELISTED
Infinite Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFNT.U
$705K 0.02%
+70,000
New +$705K
FIGS icon
800
FIGS
FIGS
$2.36B
$704K 0.02%
25,559
+4,110
+19% +$135K

Similar funds

Prelude Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Prelude Capital Management held 2,467 positions worth $3.9B, down 0.2% from $3.91B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management deployed $168M of net new capital in Q4 2021, opening 803 new positions and adding to 446 existing holdings. Its largest new stake was Hertz: 528,755 shares worth $13.2M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9.4% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Nuance Communications, Inc., an estimated $8.13M trimmed.

  • Prelude Capital Management's largest Q4 2021 buy was Hertz: 528,755 shares worth $13.2M.
  • Prelude Capital Management added most to GreenSky, Inc. Class A Common Stock in Q4 2021, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q4 2021 reduction was Nuance Communications, Inc., cutting an estimated $8.13M.
  • Prelude Capital Management fully exited Cadence Bancorporation in Q4 2021, selling an estimated $14.7M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $3.9B portfolio in Q4 2021.
  • Prelude Capital Management opened 803 new positions and closed 506 in Q4 2021.
  • Prelude Capital Management's portfolio value fell 0.2% quarter-over-quarter to $3.9B.

Based on Prelude Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.